Regional expansion There are active distribution partnerships and plans for expansion in Australia, New Zealand, and Chile, highlighting opportunities to introduce or grow sales of the Alteco LPS Adsorber in new and adjacent markets through distributor networks.

Financial leverage Recent shareholder loans indicate available liquidity to support go-to-market activities, promotions, or inventory buildup, enabling targeted outreach and channel investments to accelerate revenue growth.

Clinical need The LPS Adsorber addresses endotoxemia in sepsis, a high-mortality condition with substantial global incidence, suggesting strong demand potential in ICU centers, hospitals, and contract research settings seeking adjunctive therapies.

Small-but-mobile The company operates with a lean team but maintains ISO 13485 certification and a dedicated medical device profile, allowing nimble engagement with hospitals and distributors while ensuring regulatory credibility.

Partner-ready Existing distribution agreements and partnerships signal a ready-made path to scale through regional distributors, enabling targeted sales campaigns that emphasize exclusivity, market access, and bundled offerings.